Company intelligence / Profile preview

Qiangyao Biotech

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Qiangyao Biotech operates a professional biomedical R&D service platform, delivering peptide synthesis, protein expression, and antibody preparation to over 30,000 global clients; rigorous innovation and quality standards have elevated its status in the biomedical research support sector

Modalities: PeptidesProteinsAntibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Qiangyao Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiangyao Biotech.

Explore the full profile